Contents

Current Pharmaceutical Design, Volume 12 - Number 4

Editorial [Hot Topic: Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]

, 12(4): 395 - 396

Jean-Claude Herve


DOI: 10.2174/138161206775474495




Exploiting High-Throughput Ion Channel Screening Technologies in Integrated Drug Discovery

, 12(4): 397 - 406

J. M. Treherne


DOI: 10.2174/138161206775474440




Brain Neuronal Nicotinic Receptors as New Targets for Drug Discovery

, 12(4): 407 - 428

C. Gotti, L. Riganti, S. Vailati and F. Clementi


DOI: 10.2174/138161206775474486




Na+ Channel Pharmacology and Molecular Mechanisms of Gating

, 12(4): 429 - 442

K. Yamaoka, S. M. Vogel and I. Seyama


DOI: 10.2174/138161206775474468




L-Type Calcium Channels

, 12(4): 443 - 457

David J. Triggle


DOI: 10.2174/138161206775474503




Modulation of Potassium Channels as a Therapeutic Approach

, 12(4): 459 - 470

K. Lawson and N. G. McKay


DOI: 10.2174/138161206775474477




On the Discovery and Development of CFTR Chloride Channel Activators

, 12(4): 471 - 484

Frederic Becq


DOI: 10.2174/138161206775474459




Membrane Ion Channels and Diabetes

, 12(4): 485 - 501

P. Proks and J. D. Lippiat


DOI: 10.2174/138161206775474431




Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression

, 12(4): 503 - 515

Thomas C. Baghai, Hans-Jurgen Moller and Rainer Rupprecht


DOI: 10.2174/138161206775474422




Does Angiotensin Converting Enzyme Inhibitor Protect the Heart in Cardiac Surgery? From Laboratory to Operating Room: Clinical Application of Experimental Study

, 12(4): 517 - 526

Yasuyuki Shimada


DOI: 10.2174/138161206775474413




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science